文献速递慢性肾脏病肾小球疾病

估算肾小球滤过率与癌症风险

Estimated Glomerular Filtration Rate and the Risk of Cancer.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-03-14

在瑞典基于人群的队列中,纳入719,033名≥40岁无癌症史的个体,中位随访5年。eGFR与癌症发病率呈U形关系,eGFR较低与癌症风险轻度升高相关,主要驱动癌症为皮肤癌和泌尿生殖系统癌症,部分关联可能由检测偏倚或反向因果解释。

要点

  • eGFR与癌症风险呈U形关系,eGFR<30 ml/min时风险最高。
  • eGFR降低与皮肤癌、泌尿生殖系统癌、前列腺癌和血液系统癌风险升高相关。
  • 部分癌症关联在随访12个月后减弱,提示检测偏倚或反向因果可能。

核心结论

  • 轻至重度CKD个体癌症风险轻度升高,主要由皮肤癌和泌尿生殖系统癌症驱动,且仅部分由偏倚解释。

研究设计与样本

  • 基于斯德哥尔摩肌酐测量项目的基于人群队列,纳入719,033名≥40岁无癌症史的瑞典人,中位随访5年。

主要发现

  • 共检出64,319例癌症(占参与者9%),总随访3,338,226人年。
  • 与eGFR 90-104 ml/min相比,eGFR 30-59 ml/min的调整风险比为1.08(95%CI 1.05-1.11),eGFR<30 ml/min为1.24(95%CI 1.15-1.35)。
  • 较低eGFR层与皮肤癌、泌尿生殖系统癌、前列腺癌和血液系统癌风险升高显著相关。
  • 任何癌症、皮肤癌(非黑色素瘤)和泌尿生殖系统癌风险在整个随访期均显著升高,但注册后前12个月更高。
  • 血液系统癌和前列腺癌的关联在观察12个月后消失,提示检测偏倚和/或反向因果。

临床怎么用

  • 对CKD患者,尤其是eGFR较低者,应关注皮肤癌和泌尿生殖系统癌症的筛查。
  • 癌症风险升高部分源于检测偏倚,需结合临床情境解读关联。

局限性

  • 观察性设计不能排除残余混杂。
  • 检测偏倚和反向因果可能部分解释关联。
  • 结果基于瑞典人群,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Community-based reports regarding eGFR and the risk of cancer are conflicting. We here explore plausible links between kidney function and cancer incidence in a large Scandinavian population-based cohort. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In the Stockholm Creatinine Measurements project, we quantified the associations of baseline eGFR with the incidence of cancer among 719,033 Swedes ages ≥40 years old with no prior history of cancer. Study outcomes were any type and site-specific cancer incidence rates on the basis of International Classification of Diseases-10 codes over a median follow-up of 5 years. To explore the possibility of detection bias and reverse causation, we divided the follow-up time into different time periods (≤12 and >12 months) and estimated risks for each of these intervals. RESULTS: In total, 64,319 cases of cancer (affecting 9% of participants) were detected throughout 3,338,226 person-years. The relationship between eGFR and cancer incidence was U shaped. Compared with eGFR of 90-104 ml/min, lower eGFR strata associated with higher cancer risk (adjusted hazard ratio, 1.08; 95% confidence interval, 1.05 to 1.11 for eGFR=30-59 ml/min and adjusted hazard ratio, 1.24; 95% confidence interval, 1.15 to 1.35 for eGFR<30 ml/min). Lower eGFR strata were significantly associated with higher risk of skin, urogenital, prostate, and hematologic cancers. Any cancer risk as well as skin (nonmelanoma) and urogenital cancer risks were significantly elevated throughout follow-up time, but they were higher in the first 12 months postregistration. Associations with hematologic and prostate cancers abrogated after the first 12 months of observation, suggesting the presence of detection bias and/or reverse causation. CONCLUSIONS: There is a modestly higher cancer risk in individuals with mild to severe CKD driven primarily by skin and urogenital cancers, and this is only partially explained by bias.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Xu H, Matsushita K, Su G, et al. Estimated Glomerular Filtration Rate and the Risk of Cancer. Clin J Am Soc Nephrol. 2019. PMID: 30872279. doi:10.2215/CJN.10820918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。